Charles River Laboratories (CRL)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,596,880 | 2,976,290 | 2,534,820 | 2,114,600 | 1,634,580 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $3,596,880K
= 0.00
The debt-to-equity ratio for Charles River Laboratories has been consistently reported as 0.00 over the past five years, indicating that the company has not utilized any debt to finance its operations and growth. This suggests that Charles River Laboratories relies primarily on equity financing, which can signify a strong financial position and stability. However, it is important to note that a debt-to-equity ratio of 0.00 may also reflect that the company has no long-term debt but could have short-term liabilities or other non-debt financial obligations. Overall, a consistent debt-to-equity ratio of 0.00 implies a conservative approach to capital structure and financial management.
Peer comparison
Dec 31, 2023